SAHPRA & Egyptian Drug Authority Forge New Partnership for Pharmaceutical Progress

By Staff Writer

July 13, 2023

Exciting news from Pretoria! The South Africa Health Products Regulatory Authority (SAHPRA) has inked a groundbreaking Memorandum of Understanding (MOU) with the Egyptian Drug Authority (EDA). This monumental alliance, signed at the Egyptian Embassy, promises to foster vital collaboration and engagement on mutual reliance for pharmaceuticals, biological products, and medical devices. 

This MOU marks the first of its kind between SAHPRA and a national regulatory authority in Africa, underlining our dedication to fostering collaboration and knowledge sharing with our African counterparts. The focus? Building capacity on the continent to ensure we stay rooted in regulatory processes. 

This partnership holds potential for setting a unified vision and coordinating effective dialogue between African countries in the pharmaceutical industries sector. 

The new partnership can remove barriers to trade, enhance people-to-people relations, and create a synergistic relationship where both regulators share knowledge and engage on areas of market authorization, pharmacovigilance, Good Manufacturing Practices (GMP) and clinical trials.

Reference url

Recent Posts

drug price transparency
     

Impending Net Drug Price Transparency Regulation in the U.S.

💡 Are you ready for a potential game-changer in drug pricing transparency?

CMS Administrator Mehmet Oz has hinted at a new rule aimed at enforcing stricter disclosures for drug prices, requiring healthcare companies to reveal actual transaction costs. This could reshape how price transparency is managed across the industry and challenge pharmacy benefit managers to rethink rebate practices.

Curious about how this will impact healthcare economics and what it means for drug affordability? Dive into the article for all the insights!

#SyenzaNews #healthcare #HealthEconomics

Sword Health mental health
         

How Does Mind’s AI-Driven Mental Healthcare Transform Care?

🤔 Are we ready to embrace AI in mental health care?

Sword Health has just secured €34.6 million to launch **Mind**, an innovative AI-powered mental health solution, blending licensed clinicians with continuous monitoring through wearables. This strategic expansion aims to address the pressing global mental health crisis while promoting personalized and proactive care models. 🌍🧠

Dive into how Sword Health is revolutionizing healthcare and bridging the gap between technology and clinical expertise.

#SyenzaNews #HealthTech #AIinHealthcare #DigitalTransformation

transparency in industry partnerships
   

Transparency in Industry Partnerships: Building Trust

🔍 How does transparency in industry partnerships impact patient care?

In the evolving landscape of healthcare, EFPIA’s mandatory disclosure requirements for financial interactions underscore the vital role of transparency in fostering trust and collaboration. By detailing financial transfers to healthcare professionals and organizations, the European Disclosure Gateway facilitates informed decision-making and strengthens relationships between stakeholders.

Have a look at the article to explore how these initiatives not only enhance public confidence but also drive innovation in treatments!

#SyenzaNews #HealthcareInnovation #HealthEconomics #innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.